4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic Acid
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

pharmacompass-1-m-2026-01-12

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

Contact Supplier

Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

Contact Supplier

pharmacompass-2-2026-02-09

4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

7 API Suppliers, 4 USDMF, 2 KDMF, 2 NDC API, 3 Listed Suppliers, $ API Reference Price

7 API Suppliers
4 USDMF
2 KDMF
2 NDC API
3 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

FINISHED DOSAGE FORMULATIONS

10 FDF Dossiers, 1 FDA Orange Book, 7 Europe, 1 Canada, 1 South Africa

10 FDF Dossiers
1 FDA Orange Book
7 Europe
1 Canada
1 South Africa

DIGITAL CONTENT

4 News #PharmaBuzz

4 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

11 APIs

11 APIs

PATENTS & EXCLUSIVITIES

3 US Patents, 1 Health Canada Patents

3 US Patents
1 Health Canada Patents

$ API Ref.Price (USD/KG) : 3,203,880 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3GALDERMA LABS LP

filter Patent Number Reset all filters

3 All

01 17807708

02 19084778

03 19498465

filter API Patent Reset all filters

3 All

01 1Y

02 2Blank

filter FDF Patent Reset all filters

3 All

01 3Y

filter Expiration Date Reset all filters

3 All

01 12031-07-19

02 22033-05-30

Product Main Page

01

GALDERMA LABS LP

euroPLX 90 Lisbon

Not Confirmed

GALDERMA LABS LP

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-05-30

TRIFAROTENE

US Patent Number : 9084778

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211527

Patent Use Code : U-134

Delist Requested :

Patent Use Description : TREATMENT OF ACNE VULG...

Patent Expiration Date : 2033-05-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GALDERMA LABS LP

euroPLX 90 Lisbon

Not Confirmed

GALDERMA LABS LP

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-05-30

TRIFAROTENE

US Patent Number : 9498465

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211527

Patent Use Code : U-1033

Delist Requested :

Patent Use Description : TOPICAL TREATMENT OF A...

Patent Expiration Date : 2033-05-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GALDERMA LABS LP

euroPLX 90 Lisbon

Not Confirmed

GALDERMA LABS LP

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-07-19

TRIFAROTENE

US Patent Number : 7807708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211527

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-07-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.